Company Encyclopedia
View More
name
WHOLE SHINE MEDICAL
002622.SZ
Whole Shine Medical Technology Co., Ltd. engages in the oral medical services business in China. The company is also involved in the research and development, production, and sale of permanent magnet switches and high and low voltage switch complete sets of equipment products; provision of high-voltage switchgears, low voltage switchgear of other models, permanent magnet indoor high voltage vacuum breaker, circuit breakers, as well as permanent magnet high voltage vacuum circuit breakers for arc furnaces and contactors, switch state controllers, and outdoor box-type substations. In addition, it offers diagnosis and treatment of oral diseases, oral health care and restoration services; accepts deposits; grants loans; and banking business.
82.57 B
002622.SZMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
D
Health Care ServicesIndustry
Industry Ranking8/8
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-19.11%E
    • Profit Margin-10.30%D
    • Gross Margin54.43%B
  • Growth ScoreD
    • Revenue YoY-13.21%E
    • Net Profit YoY20.16%B
    • Total Assets YoY-7.16%D
    • Net Assets YoY-16.51%E
  • Cash ScoreE
    • Cash Flow Margin-970.95%E
    • OCF YoY-13.21%E
  • Operating ScoreC
    • Turnover0.5C
  • Debt ScoreD
    • Gearing Ratio71.72%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    CITIC Construction Investment: Long-term optimism for innovative drugs and high-end medical devices; expansion of commercial health insurance may become a new engine for the pharmaceutical industry

    CITIC Construction Investment released a research report, expressing a long-term positive outlook on innovative drugs and high-end medical equipment, believing that the expansion of commercial health insurance will bring a new growth engine to the pharmaceutical industry. It is expected that the scale of commercial health insurance will reach 977.3 billion yuan in 2024, with a CAGR of 6.7% from 2019 to 2024. The industry needs to make progress in data sharing and insurance coverage rates to promote incremental development in the pharmaceutical sector

    Zhitong·
    SZ
    002622
    +2.12%
    SZ
    301235
    +2.46%
    HK
    02158
    +0.78%
    Zhitong·
    SZ
    002622
    +2.12%
    SZ
    301235
    +2.46%
    HK
    02158
    +0.78%

    The healthcare services sector surged significantly in early trading

    The medical services sector surged sharply at the beginning of trading, with GOODWILL, Thalys, Berry Genomics, Meinian Onehealth, and WHOLE SHINE MEDICAL all hitting the daily limit up

    Zhitong·
    SH
    688246
    +1.71%
    SH
    603716
    +0.99%
    SZ
    000710
    +1.57%
    Zhitong·
    SH
    688246
    +1.71%
    SH
    603716
    +0.99%
    SZ
    000710
    +1.57%

    It is reported that the State-owned Assets Supervision and Administration Commission is planning to establish a new central enterprise to integrate and develop national-level data resources

    According to reports, the State-owned Assets Supervision and Administration Commission of the State Council is in the process of establishing a new central enterprise called "National Data Group," aimed at integrating and developing national-level data resources, promoting the interconnection and market-oriented allocation of data resources. This central enterprise will cover multiple key areas such as energy, transportation, finance, and healthcare, facilitating the cross-industry and cross-regional flow and sharing of data resources. This initiative aims to address the issues of decentralization and fragmentation of data resources, with the domestic data circulation market expected to reach a scale of 500 billion to 1 trillion yuan during the 14th Five-Year Plan period

    Yahoo Asia·
    SZ
    301235
    +2.46%
    SH
    688139
    -1.56%
    SZ
    002622
    +2.12%
    Yahoo Asia·
    SZ
    301235
    +2.46%
    SH
    688139
    -1.56%
    SZ
    002622
    +2.12%

    The medical insurance department will regularly disclose the "financial status" of medical institutions

    Under the guidance of the National Healthcare Security Administration, Hefei City in Anhui Province held a targeted release event for healthcare insurance data. Local healthcare insurance departments will regularly disclose healthcare insurance data to medical institutions, promote information sharing, improve fund utilization efficiency, and ensure fund security. Local healthcare insurance departments will publish data monthly or quarterly, with at least one release of healthcare insurance data in all coordinated areas nationwide by March 31, 2025

    Zhitong·
    SH
    600998
    +0.59%
    SZ
    301235
    +2.46%
    SZ
    002622
    +2.12%
    Zhitong·
    SH
    600998
    +0.59%
    SZ
    301235
    +2.46%
    SZ
    002622
    +2.12%

    Guotai Junan Securities: The Chinese medical and health industry welcomes the "Deepseek Moment" with huge potential in the AI medical and AI pharmaceutical markets

    Guotai Junan Securities released a research report pointing out that the AI medical and AI pharmaceutical markets have enormous potential, becoming important application areas for AI technology. With digital transformation and intelligent upgrades, the domestic AI pharmaceutical/medical field has broad prospects. The global AI solutions market is growing rapidly, with healthcare being one of the largest application areas, and it is expected that the market size will reach USD 1,414.2 billion by 2030

    Zhitong·
    SZ
    002622
    +2.12%
    HK
    02158
    +0.78%
    SZ
    301235
    +2.46%
    Zhitong·
    SZ
    002622
    +2.12%
    HK
    02158
    +0.78%
    SZ
    301235
    +2.46%
    © 2025 Longbridge｜Disclaimer